Epigenetic Modulating Agents as a New Therapeutic Approach in Multiple Myeloma

Author： Maes Ken   Menu Eline   Van Valckenborgh Els   Van Riet Ivan   Vanderkerken Karin   De Bruyne Elke  

Publisher： MDPI

E-ISSN： 2072-6694|5|2|430-461

ISSN： 2072-6694

Source： Cancers, Vol.5, Iss.2, 2013-04, pp. : 430-461

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Role of Immunotherapy in Multiple Myeloma

By Kocoglu Mehmet   Badros Ashraf  

Pharmaceuticals, Vol. 9, Iss. 1, 2016-01 ,pp. : 3-3

MDPI

Access to resources Recommend Favorite

Development of Novel Immunotherapies for Multiple Myeloma

By Al-Hujaily Ensaf M.   Oldham Robyn A. A.   Hari Parameswaran   Medin Jeffrey A.  

International Journal of Molecular Sciences, Vol. 17, Iss. 9, 2016-09 ,pp. : 1506-1506

MDPI

Access to resources Recommend Favorite

Epigenetic Mechanisms and Therapeutic Perspectives for Neurodevelopmental Disorders

By Kubota Takeo   Takae Hirasawa   Miyake Kunio  

Pharmaceuticals, Vol. 5, Iss. 4, 2012-04 ,pp. : 369-383

MDPI

Access to resources Recommend Favorite

Tyrosine Kinase Inhibitors as Antiangiogenic Drugs in Multiple Myeloma

By Ribatti Domenico  

Pharmaceuticals, Vol. 3, Iss. 4, 2010-04 ,pp. : 1225-1231

MDPI

Access to resources Recommend Favorite

Clinical Use of Proteasome Inhibitors in the Treatment of Multiple Myeloma

By Merin Noah M.   Kelly Kevin R.  

Pharmaceuticals, Vol. 8, Iss. 1, 2014-12 ,pp. : 1-20

MDPI

Access to resources Recommend Favorite